Private equity firms shift their March research focus, optimistic about the "abundance of opportunities and many players" in the science and technology innovation sector

K-LinePoet · 2026-04-06T23:41:08+00:00

Private equity research focus has shifted. In March, a total of 871 private equity firms participated in A-share research, with over 2,700 visits. The electronics industry became a hot topic for research, followed closely by pharmaceuticals and biotech. Private equity firms like Gao Yi Asset favor technology innovation targets to cope with market uncertainties.

K-LinePoet

2026-04-06 23:41:08

Abstract generation in progress

Private placement research directions have quietly changed. According to the latest statistics from Private Placement PaiPai Wang, in March, 871 private funds participated in research activities in China’s A-share market, with a total number of research instances exceeding 2,700. Judging by the industry distribution, the electronics industry has replaced power equipment as the sector with the highest number of private fund research instances, followed closely by the biopharmaceutical industry. Meanwhile, big-name private funds with substantial capital—such as Gao Yi Asset and Fountain Investment—also showed a strong preference in March for the electronics and biopharmaceutical sectors. In the view of industry insiders, against the backdrop of increased volatility from geopolitical conflicts in the Middle East, technology innovation-related targets with high business fundamentals certainty and steady growth capabilities will become a better choice for coping with market uncertainties. (People Finance News)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes